Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031210270Completed
Open-label, single-arm trial of verapamil, sponsored by Japan Society for the Promotion of Science. Primary endpoints: AUC0-24 of plasma verapamil hydrochloride and Cmax of plasma verapamil hydrochloride. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031210270.